← FDA DRUG APPROVALS

FDA ANDA · ANDA204306

DICLOFENAC SODIUM

Sponsor: AUROLIFE PHARMA LLC

APPLICATION
ANDA204306
TYPE
ANDA
ORIGINAL APPROVAL
2019-05-06
LATEST ACTION
2023-05-10
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Over-the-counter

Products

DICLOFENAC SODIUMOver-the-counter
DICLOFENAC SODIUM 1% · GEL · TOPICAL

Approval history

2023-05-10Manufacturing (CMC) · Supplement 6AP
2020-08-06Manufacturing (CMC) · Supplement 1AP
2019-05-06UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →